G. Kumar

Cost-effectiveness analysis of sequential biologic therapy with ixekizumab versus secukinumab as first-line treatment of moderate-to-severe psoriasis in the UK

A. Svedbom, S. Hartz, E. Johansson, 2018, Journal of medical economics.

Cost-Effectiveness Analysis of Ixekizumab vs. Secukinumab in Sequential Biologic Treatment of Psoriasis in the UK

A. Svedbom, S. Hartz, E. Johansson, 2016 .

Long-Term Cost-Effectiveness of Transanal Irrigation in Patients with Neurogenic Bowel Dysfunction

Z. Størling, A. Emmanuel, S. Kirshblum, 2016, PloS one.

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis

A. Ruyssen-Witrand, R. Perry, C. Sapin, 2020, RMD Open.

Cost-Effectiveness Analysis of Sequential Biologic Therapy with Ixekizumab Versus Secukinumab in the Treatment of Active Psoriatic Arthritis with Concomitant Moderate-to-Severe Psoriasis in the UK

B. Schweikert, C. Malmberg, C. Sapin, 2020, PharmacoEconomics - Open.

Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection

E. Fenwick, M. Sohail, S. Eggington, 2018, Journal of medical economics.

Cost-effectiveness of first-line induction and maintenance treatment sequences in non-squamous non-small cell lung cancer (NSCLC) in the U.S.

B. Woods, P. Bryden, L. Hess, 2015, Lung cancer.